Cargando…

Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants with increased levels of reactive oxygen species (ROS) and ferroptosis. Herein, we designed a peptide-based nanoparticle to deliver therapeutic molecules to pulmonary, thereby ameliorating BPD. The BPD-induced damages of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Jiang, Chen, Xu, Xu, Fengdan, Tao, Fangfei, Liu, Liyuan, Cheng, Rui, Li, Ning, Pan, Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687138/ https://www.ncbi.nlm.nih.gov/pubmed/38030848 http://dx.doi.org/10.1007/s00604-023-06069-3

Ejemplares similares

Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019)

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022)

Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort
por: Zayat, Noura, et al.
Publicado: (2022)

Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021)

Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)
por: Löfqvist, Chatarina, et al.
Publicado: (2012)

Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
por: Wang, Xuting, et al.
Publicado: (2022)

Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
por: Onland, Wes, et al.
Publicado: (2018)

Respiratory Morbidity and Lung Function Analysis During the First 36 Months of Life in Infants With Bronchopulmonary Dysplasia (BPD)
por: Chen, Dandan, et al.
Publicado: (2020)

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
por: van Katwyk, Sasha, et al.
Publicado: (2020)

A comparison of newer classifications of bronchopulmonary dysplasia: findings from the Children’s Hospitals Neonatal Consortium Severe BPD Group
por: Vyas-Read, Shilpa, et al.
Publicado: (2021)

New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks
por: Geetha, Odattil, et al.
Publicado: (2021)

Pathogenesis of bronchopulmonary dysplasia in preterm neonates revealed by an RNA sequencing interaction network analysis
por: Xu, Fengdan, et al.
Publicado: (2022)

Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
por: Onland, Wes, et al.
Publicado: (2011)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

BPD, Not BPD, or Iatrogenic BPD: Findings of Lung Ultrasound Examinations
por: Liu, Jing, et al.
Publicado: (2014)

Integration of transcriptomics reveals ferroptosis-related signatures and immune cell infiltration in bronchopulmonary dysplasia
por: Hu, Zhengyun, et al.
Publicado: (2023)

ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis
por: Yang, Min, et al.
Publicado: (2023)

Genetic analysis of potential biomarkers and therapeutic targets associated with ferroptosis from bronchopulmonary dysplasia
por: Ma, Xiaoxue, et al.
Publicado: (2023)

Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic
por: Ruran, Hana B, et al.
Publicado: (2021)

The high-risk factors of different severities of bronchopulmonary dysplasia (BPD) based on the national institute of child health and human development (NICHD) diagnosis criteria in 2018
por: Jian, Minqiao, et al.
Publicado: (2021)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial)
por: Wu, Xian, et al.
Publicado: (2020)

Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
por: Balink, Stephanie, et al.
Publicado: (2022)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

A predictive model for preterm infants with bronchopulmonary dysplasia based on ferroptosis-related lncRNAs
por: Zhang, Ziming, et al.
Publicado: (2023)

GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice
por: Sonny, Sarah, et al.
Publicado: (2023)

The clinical value of lung ultrasound in premature infants with bronchopulmonary dysplasia
por: Xu, Jingyi, et al.
Publicado: (2023)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Bronchopulmonale Dysplasie (BPD)
por: Herting, E.
Publicado: (2013)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
por: Das, Pragnya, et al.
Publicado: (2018)

Exploring right ventricular function applicability in a prediction model to identify preterm infants with early bronchopulmonary dysplasia (REPORT-BPD study): a mixed-methods observational cohort feasibility study protocol
por: Muhsen, Wisam S., et al.
Publicado: (2022)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nsgcm92ne0d5eomcjj6e6i28km